October 4, 2011

 On-Q-ity CSO and Interim President, Walt Carney (right). Example of size-selective gradient chip design (left).

 

Thanks to Bruce Booth for mentioning this article in Drug Discovery Today by Walt Carney, Chief Scientific Officer and Interim President of On-Q-ity.  We’ve...

March 13, 2011

On March 21, On-Q-Ity’s Mara Aspinall will be speaking at the upcoming MassBio Annual Meeting in Cambridge, MA focused on personalized medicine.  On-Q-Ity is developing microfluidic diagnostics for detecting rare circulating tumor cells (CTCs) and was featured in aFlui...

December 7, 2010

Multifunctional nanoparticle for diagnosis and treatment. Image credit: Sangeeta Bhatia

 

 

Triggered self-assembly of nanoparticles by tumor protease (MMP-2). Image credit: Sangeeta Bhatia

 

Another great talk this week at MIT from the MNSS Seminar Series to close out the...

September 13, 2010

 On-Q-ity is commercializing a microfluidic approach developed at MGH for capturing rare circulating tumor cells for quantification and analysis. Image credit: Lecia V. Sequist, Sunitha Nagrath, Mehmet Toner, Daniel A. Haber, and Thomas J. Lynch

 

One of the most lethal...

January 17, 2010

What causes cancer cells to become metastatic, moving beyond their local environment to infiltrate other parts of the body? Some researchers have called metastasis “the most dangerous event in cancer,” and many believe that a better understanding of metastasis could le...

Please reload

Featured Posts
Recent Posts
Please reload

Archive
Please reload

Search By Tags